Skip to main content
Journal of Clinical and Experimental Hepatology logoLink to Journal of Clinical and Experimental Hepatology
. 2011 Nov 9;1(2):118–120. doi: 10.1016/S0973-6883(11)60132-1

Auxiliary Liver Transplantation: A Form of Gene Therapy in Selective Metabolic Disorders

Naresh P Shanmugam 1, Rajasekhar Perumalla 1, RG Gopinath 1, A Olithselvan 1, Joy Varghese 1, Dharmesh Kapoor 1, Mohmed Rela 1,*
PMCID: PMC3940636  PMID: 25755324

Abstract

Auxiliary liver transplantation is an accepted form of therapy in acute liver failure and in certain metabolic disorders. We report India's first successful auxiliary liver transplantation for Crigler-Najjar syndrome type 1, showing that it is technically feasible and safe procedure. It is utmost important to select appropriate cases for auxiliary transplant for successful long-term outcome. The surgeon should also have an understanding of the portal flow dynamics, as steal phenomenon can occur, depriving blood blow to either graft or native liver. Though successful in animal models, gene therapy is still in experimental stage in humans and pace of progress has been disappointing. Auxiliary liver transplantation retains the native liver for future gene therapy. These children are young and are likely to have a long life expectancy, and withdrawal of immunosuppression would be a huge advantage.

Keywords: Acute liver failure, auxiliary liver transplant, Crigler-Najjar syndrome, gene therapy, pediatric transplantation

Abbreviations: ALF, acute liver failure; APOLT, auxiliary partial orthotopic liver transplants; CNS1, Crigler-Najjar syndrome type 1

Full Text

The Full Text of this article is available as a PDF (241.6 KB).

References

  • 1.Sze YK, Dhawan A, Taylor RM. Pediatric liver transplantation for metabolic liver disease: experience at King's College Hospital. Transplantation. 2009;87:87–93. doi: 10.1097/TP.0b013e31818bc0c4. [DOI] [PubMed] [Google Scholar]
  • 2.Rela M, Battula N, Madanur M. Auxiliary liver transplantation for propionic acidemia: a 10-year follow-up. Am J Transplant. 2007;7:2200–2203. doi: 10.1111/j.1600-6143.2007.01899.x. [DOI] [PubMed] [Google Scholar]
  • 3.Morioka D, Takada Y, Kasahara M. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation. 2005;80:623–628. doi: 10.1097/01.tp.0000167995.46778.72. [DOI] [PubMed] [Google Scholar]
  • 4.Faraj W, Dar F, Bartlett A. Auxiliary liver transplantation for acute liver failure in children. Ann Surg. 2010;251:351–356. doi: 10.1097/SLA.0b013e3181bdfef6. [DOI] [PubMed] [Google Scholar]
  • 5.Yabe S, Egawa H, Inomata Y. Auxiliary partial orthotopic liver transplantation from living donors: significance of portal blood flow. Transplantation. 1998;66:484–488. doi: 10.1097/00007890-199808270-00012. [DOI] [PubMed] [Google Scholar]
  • 6.Rela M, Muiesan P, Vilca-Melendez H. Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg. 1999;229:565–569. doi: 10.1097/00000658-199904000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Broering DC, Walter J, Bassas AF. Overcoming the portal steal phenomenon in auxiliary partial orthotopic liver transplantation by modulation of the venous outflow of the native liver. Liver Transpl. 2005;11:1140–1143. doi: 10.1002/lt.20535. [DOI] [PubMed] [Google Scholar]
  • 8.Tada K, Roy-Chowdhury N, Prasad V. Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. Cell Transplant. 1998;7:607–616. doi: 10.1177/096368979800700611. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical and Experimental Hepatology are provided here courtesy of Elsevier

RESOURCES